No Data
No Data
Mizuho Securities Downgrades Sabra Health Care REIT Inc(SBRA.US) to Hold Rating, Raises Target Price to $20
Mizuho Downgrades Sabra Health Care REIT to Neutral From Outperform
Express News | Mizuho Downgrades Sabra Health Care REIT to Neutral, Maintains Price Target to $20
Sabra Health Care REIT Analyst Ratings
BofA Securities Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Announces Target Price $21
Jefferies Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Raises Target Price to $21
Unlock the Full List